Measurement of hemoglobin A1c from filter papers for population-based studies

Clinical Chemistry

Volumn 57, Issue 4, 2011, Pages 577-585

  Egier, David A ^a   Keys, Judy L ^a   Hall, S Kim ^a   McQueen, Matthew J ^a,b,c  

^a HAMILTON GENERAL HOSPITAL   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ACCURACY; ARTICLE; BETA THALASSEMIA; CHROMATOGRAPHY; CLINICAL TRIAL; FILTER; FILTER PAPER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MORPHOMETRICS; MULTICENTER STUDY; POPULATION RESEARCH; RISK FACTOR; UNSTABLE ANGINA PECTORIS; HEALTH SURVEY; PAPER; VALIDATION STUDY;

ANGINA;

HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PAPER; POPULATION SURVEILLANCE;

EID: 79956107797     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.156380     Document Type: Article

References (31)

1. International Diabetes Federation. IDF diabetes atlas. 4th ed. Brussels (Belgium): International Diabetes Federation; 2009.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-9.
5. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JC, et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes 2006;55:3556-65. (Pubitemid 44923617)
6. Krishnamurti U, Steffes MW. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem 2001;47:1157-65. (Pubitemid 32579102)
7. Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23:187-91. (Pubitemid 30071022)
8. Chandalia HB, Krishnaswamy PR. Glycated hemoglobin. Curr Sci 2002;83:1522-32. (Pubitemid 135698201)
9. Eckfeldt JH, Bruns DE. Another step toward standardization of methods for measuring hemoglobin A1c. Clin Chem 1997;43:1811-3.
10. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984;310:341-6. (Pubitemid 14179538)
11. Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007;50:2239-44. (Pubitemid 47512407)
12. Fitzgibbons JF, Kolar RD, Jones RT. Red cell agerelated changes of hemoglobins A1a+b and A1c in normal and diabetic patients. J Clin Invest 1976;58:820-4.
13. Tahara Y, Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care 1993;16:1313-4. (Pubitemid 23259881)
14. Little R, Rohlfing C, Tennill A, Connolly S, Hanson S. Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods. Diabetes Technol Ther 2007;9:36-42.
15. 1c) measurements from frozen whole blood samples stored for over a decade. Diabet Med 2005;22:1726-30.
16. Wikblad K, Smide B, Bergstrom A, Wahren L, Mugusi F, Jeppsson JO. Immediate assessment of HbA1c under field conditions in Tanzania. Diabetes Res Clin Pract 1998;40:123-8. (Pubitemid 28308402)
17. Jeppsson JO, Jerntorp P, Almer LO, Persson R, Ekberg G, Sundkvist G. Capillary blood on filter paper for determination of HbA1c by ion exchange chromatography. Diabetes Care 1996;19:142-5.
18. Anjali, Geethanjali FS, Kumar RS, Seshadri MS. Accuracy of filter paper method for measuring glycated hemoglobin. J Assoc Physicians India 2007;55:115-9.
19. 1c sampling kit. Diabetes Technol Ther 1999;1:411-9.
20. Fokkema MR, Bakker AJ, de Boer F, Kooistra J, de Vries S, Wolthuis A. HbA1c measurements from dried blood spots: validation and patient satisfaction. Clin Chem Lab Med 2009;47:1259-64.
21. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. (Pubitemid 39208455)
22. Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, et al. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur J Cardiovasc Prev Rehabil 2007;14:312-8. (Pubitemid 46650089)
23. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72. (Pubitemid 34174577)
24. Goldstein D, Little R, Lorenz R, Malone J, Nathan D, Peterson C, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-73. (Pubitemid 38857461)
25. Lahousen T, Roller RE, Lipp RW, Schnedl WJ. Silent haemoglobin variants and determination of HbA1c with the HPLC Bio-Rad Variant II. J Clin Pathol 2002;55:699-703. (Pubitemid 34970094)
26. Joutovsky A, Hadzi-Nesic J, Nardi M. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60,000 samples in a clinical diagnostic laboratory. Clin Chem 2004;50:1736-47. (Pubitemid 39298002)
27. Higgins T, Ridley B. Tentative identification of hemoglobin variants in the Bio-Rad Variant II HbA1c method. Clin Biochem 2005;38:272-7. (Pubitemid 40227430)
28. Higgins TN, Blakney GB, Dayton J. Analytical evaluation of the Bio-Rad Variant II automated HbA1C analyzer. Clin Biochem 2001;34:361-5. (Pubitemid 32777843)
29. Lafferty JD, McFarlane AG, Chui DHK. Evaluation of a dual hemoglobin A2/A1c quantitation kit on the Bio-Rad Variant II automated hemoglobin analyzer. Arch Pathol Lab Med 2002;126:1494-500. (Pubitemid 36237256)
30. Moridani M, Verjee Z, Allen L. Analytical evaluation of hemoglobin A1c dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients. Clin Biochem 2003;36:317-20. (Pubitemid 36694977)
31. Jones TG, Warber KD, Roberts BD. Analysis of hemoglobin A1c from dried blood spot samples with the Tina-quant II immunoturbidimetric method. J Diabetes Sci Technol 2010;4:244-9.